AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript

AZN earnings call for the period ending December 31, 2023.

Related Keywords

United States ,Germany ,China ,Cambridge ,Cambridgeshire ,United Kingdom ,Spain ,Japan ,London ,City Of ,Australia ,Sweden ,Qingdao ,Shandong ,Dublin ,Ireland ,Australian ,Chinese ,James Gordon ,Mark Purcell ,James Gordon Jpmorgan ,Peter Welford ,Mark Purcell Morgan Stanley ,Simon Baker Redburn ,Luisa Hector Berenberg ,Matthew Weston ,Sandy Barnett ,Sundal Collier ,Andrew Baum ,Redburn Atlantic ,Tim Anderson ,Daiichi Sankyo ,Iskra Reic ,Luisa Hector ,Eric Berg ,Gonzalo Artiach ,Simon Baker ,Marc Dunoyer ,Pascal Soriot ,Peter Welford Jefferies ,Andrew Baum Citi ,Morgan Stanley ,Eric Le Berrigaud Stifel Financial Corp ,Tim Anderson Wolfe Research Analyst ,Biopharmaceuticals Research ,Astrazeneca Plc ,Academic Group ,Barclays ,Zenith ,Members Of The Executive Team ,London Stock Exchange ,Wolfe Research ,Company Analyst ,Oncology Research ,Astrazeneca ,Im Andy Barnett ,Executive Team ,Motley Fool Stock Advisor ,Stock Advisor ,Quell Cellectis ,Pfizer Gene Therapy ,Vice President ,Destiny Breast ,Fast Track ,Executive Officer ,Chief Strategy Officer ,Lora Tagrisso Destine ,Emily Field ,Medicare Part ,Boston Renan ,Proposed Marc ,Japan Imfinzi ,Tagrissoi M ,Capital Markets ,Tagrisso Rest ,World Beat ,Redburn Partners ,Berenberg Capital Markets ,Executive Vice President ,Chief Executive Officer ,Aradhana Sarin ,Dave Fredrickson ,Ruud Dobber ,Operating Margin ,Rare Disease ,